Seeking scientific research partners for ERC/other grant applications

HO2Rx is a soon-to-be European startup Biotech pioneering game-changing therapies to disrupt the X 100B € Chronic Inflammatory Disease market, to help hundreds of millions of patients finally reclaim their lives. Our versatile platform of preclinical prodrugs builds upon >15Y of collaborative research at top US institutions (e.g., WISTAR, UC, Northwestern Univ, Penn). Our first revenues (licensing) expected within 2Y should fund 75% of the total development of our lead candidate for periodontitis- our demonstration indication to enter the competitive CID market. Based on human POC in periodontitis, we will move to IBD and other chronic inflammation indications. We seek research teams interested in co-applying for ERC and other grants to fund important projects focused on strengthening the scientific differentiation of our 2 lead drug candidates and expanding product development avenues. Specifics can be discussed off-line. Down the line, these collaborations could support HO2Rx R&D team building through hiring, consulting, and/or SAB appointments.